浮针治疗急性不完全性肠梗阻气机壅滞证临床研究

Clinical Study of Fu's Subcutaneous Needling in Treating Acute Incomplete Intestinal Obstruction with Qi Stagnation Syndrome

摘要:

目的：观察浮针疗法治疗急性不完全性肠梗阻气机壅滞证的临床疗效。方法：选取2022年8月—2024年8月广州中医药大学第二附属医院急诊科收治的急性不完全性肠梗阻气机壅滞证患者48例，采用简单随机化方法分为对照组与治疗组各24例。对照组给予西医常规治疗，治疗组在西医常规治疗基础上联合浮针疗法。连续治疗5天。观察比较2组临床疗效及安全性、临床症状改善时间、中医证候评分、血清超敏C-反应蛋白（hs-CRP） 和白细胞计数（WBC） 水平。结果：治疗后，治疗组总有效率为100% （24/24），对照组为95.80%（23/24），2组比较，差异无统计学意义（P＞0.05）。治疗后，治疗组腹痛缓解时间、肠鸣音恢复时间、首次排气时间、首次排便时间、住院时间均短于对照组，差异有统计学意义（P＜0.05）。治疗后，2组中医证候评分均较治疗前降低，且治疗组评分低于对照组，差异均有统计学意义（P＜0.05）。治疗后，2组hs-CRP、WBC水平均较治疗前降低，且治疗组2项指标水平均低于对照组，差异均有统计学意义（P＜0.05）。治疗期间，2组均未出现与治疗相关的不良反应。结论：浮针疗法联合西医常规治疗不完全性肠梗阻气机壅滞证疗效确切，可有效改善其临床症状，促进胃肠功能恢复，下调炎症指标水平，且安全性良好。

Abstract:

Abstract： Objective： To observe the clinical efficacy of Fu's subcutaneous needling （FSN） in treating acute incomplete intestinal obstruction with stagnation syndrome. Methods： A total of 48 patients with acute incomplete intestinal obstruction with qi stagnation syndrome admitted to the Emergency Department of the Second Affiliated Hospital of Guangzhou University of Chinese Medicine from August 2022 to August 2024 were selected and randomly divided into a control group and a treatment group using a simple randomization method，with 24 cases in each group. The control group received conventional western medical treatment，while the treatment group received FSN in addition to conventional western medical treatment. Both groups were treated continuously for five days. Clinical efficacy，safety， symptom improvement time， traditional Chinese medicine syndrome scores， and serum levels of high-sensitivity Creactive protein （hs-CRP） and white blood cell count （WBC） were observed and compared between the two groups. Results：After treatment，the total effective rate was 100%（ 24/24） in the treatment group and 95.80%（ 23/24） in the control group，with no significant difference （P＞0.05）. The treatment group showed shorter times for abdominal pain relief， bowel sound recovery， first flatus， first defecation， and hospital stay compared to the control group， with significant differences （P＜0.05）. Traditional Chinese medicine syndrome scores decreased in both groups after treatment，with lower scores in the treatment group （P＜0.05）. Levels of hs-CRP and WBC decreased in both groups after treatment， with lower levels in the treatment group （P＜0.05）. No adverse reactions related to treatment were observed in either group during treatment. Conclusion： FSN combined with conventional western medical treatment demonstrates definite efficacy in acute incomplete intestinal obstruction with qi stagnation syndrome， effectively improving clinical symptoms，promoting gastrointestinal function recovery，lowering levels of inflammatory indicators， and exhibiting good safety.